AWS GraphRAG deployment cuts drug research cycles by 87%

A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph.

Historically, initial data gathering…